Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
3.90
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-1.69 Insider Own17.77% Shs Outstand27.92M Perf Week39.29%
Market Cap108.89M Forward P/E- EPS next Y-0.94 Insider Trans0.00% Shs Float22.96M Perf Month-2.74%
Income-37.65M PEG- EPS next Q-0.38 Inst Own18.78% Short Float2.83% Perf Quarter-23.53%
Sales0.00M P/S- EPS this Y-32.40% Inst Trans-42.95% Short Ratio1.88 Perf Half Y-17.02%
Book/sh-0.41 P/B- EPS next Y43.50% ROA-255.91% Short Interest0.65M Perf Year-6.47%
Cash/sh0.18 P/C21.91 EPS next 5Y- ROE-636.05% 52W Range2.67 - 9.25 Perf YTD-24.27%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-57.84% Beta-0.02
Dividend TTM- Quick Ratio0.41 Sales past 5Y0.00% Gross Margin- 52W Low46.07% ATR (14)0.33
Dividend Ex-Date- Current Ratio0.41 EPS Y/Y TTM-50.17% Oper. Margin0.00% RSI (14)59.14 Volatility13.92% 9.23%
Employees10 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-139.31% Payout- Rel Volume0.00 Prev Close3.90
Sales Surprise- EPS Surprise-23.35% Sales Q/Q- EarningsNov 14 AMC Avg Volume346.07K Price3.90
SMA2016.19% SMA502.17% SMA200-13.07% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Sep-20-23Initiated ROTH MKM Buy $12
Jun-08-23Initiated The Benchmark Company Speculative Buy $17
Jan-24-22Initiated H.C. Wainwright Buy $10
Today 08:00AM
Mar-26-24 08:00AM
Mar-11-24 08:00AM
Mar-07-24 08:00AM
Feb-20-24 08:00AM
08:00AM Loading…
Feb-06-24 08:00AM
Jan-25-24 08:00AM
Jan-10-24 08:00AM
Jan-04-24 08:00AM
Dec-15-23 08:35AM
Dec-12-23 01:02PM
Dec-11-23 08:35AM
Nov-30-23 04:05PM
Nov-20-23 04:05PM
Nov-16-23 08:00AM
05:23PM Loading…
Nov-14-23 05:23PM
04:01PM
Nov-01-23 05:30AM
Oct-30-23 07:54AM
07:37AM
07:30AM
Sep-29-23 09:00AM
Sep-25-23 06:00AM
Sep-22-23 01:30PM
Sep-07-23 06:00AM
Aug-18-23 06:40AM
Aug-17-23 06:00AM
Aug-14-23 04:01PM
Aug-02-23 12:45PM
Jul-31-23 08:00AM
06:00AM Loading…
Jun-26-23 06:00AM
Jun-22-23 06:00AM
Jun-15-23 06:00AM
May-25-23 06:00AM
May-22-23 06:30AM
May-19-23 06:30AM
May-18-23 06:30AM
May-17-23 05:41AM
May-15-23 04:05PM
May-12-23 06:30AM
May-11-23 06:30AM
May-04-23 06:00AM
May-01-23 04:01PM
Apr-25-23 07:00AM
Apr-20-23 04:05PM
Apr-19-23 09:00AM
Apr-04-23 06:02AM
Mar-30-23 07:30AM
Mar-10-23 04:50AM
Mar-07-23 08:00AM
Jan-31-23 07:09AM
06:00AM
Jan-25-23 08:00AM
Jan-04-23 06:00AM
Dec-16-22 05:25AM
Dec-15-22 09:05AM
06:00AM
Nov-21-22 06:00AM
Nov-17-22 05:10AM
Nov-14-22 04:05PM
Nov-05-22 09:42AM
Oct-31-22 08:00AM
Oct-13-22 06:00AM
Sep-26-22 06:00AM
Sep-07-22 08:02AM
Sep-06-22 08:30AM
Aug-31-22 06:25PM
Aug-24-22 07:07AM
Aug-19-22 06:02AM
Aug-15-22 04:15PM
Jul-27-22 07:15AM
Jul-02-22 08:21AM
Jun-24-22 08:35AM
Jun-21-22 04:21PM
Jun-17-22 08:00AM
Jun-02-22 06:00AM
May-19-22 11:42AM
May-17-22 08:30AM
May-16-22 04:05PM
May-03-22 06:00AM
Apr-26-22 06:00AM
Mar-24-22 07:30AM
Mar-22-22 08:00AM
Mar-18-22 08:00AM
Mar-17-22 08:26AM
Mar-15-22 05:16PM
Feb-01-22 06:00AM
Jan-11-22 04:58AM
Jan-10-22 06:00AM
Dec-20-21 07:00AM
Nov-16-21 10:40AM
Nov-15-21 08:15AM
Sep-15-21 08:30AM
Sep-02-21 08:30AM
Aug-25-21 06:00AM
Aug-16-21 08:15AM
Jun-28-21 07:00AM
Jun-21-21 06:50PM
May-26-21 08:43PM
May-17-21 08:21AM
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.